5-溴-2-碘三氟甲苯 | 364-12-5

• 物质功能分类: 有机原料 - 有机氟化合物 - 氟甲苯系列
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 5-溴-2-碘三氟甲苯
• 中文别名: 2-碘-5-溴三氟甲苯
• 英文名称: 4-bromo-1-iodo-2-(trifluoromethyl)benzene
• 英文别名: 5-bromo-2-iodobenzotrifluoride；4-bromo-2-(trifluoromethyl)-1-iodobenzene
• CAS: 364-12-5
• 化学式: C₇H₃BrF₃I
• 分子量: 350.905
• InChiKey: FTIZUXGKTNJZEG-UHFFFAOYSA-N

物化性质

• 熔点：
  73-75°C
• 沸点：
  238.6±40.0 °C(Predicted)
• 密度：
  2.176±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R20/21/22
• 海关编码：
  2903999090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  冷藏保存。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-Bromo-1-iodo-2-(trifluoromethyl)benzene
Synonyms: 5-Bromo-2-iodobenzotrifluoride

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-Bromo-1-iodo-2-(trifluoromethyl)benzene
CAS number: 364-12-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H3BrF3I
Molecular weight: 350.9

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride, hydrogen bromide, hydrogen Iodide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-溴-2-碘三氟甲苯 在 potassium fluoride 、 三氯异氰尿酸 作用下， 以 乙腈 为溶剂， 反应 24.0h， 以93%的产率得到[4-Bromo-2-(trifluoromethyl)phenyl]-difluoro-lambda3-iodane
  参考文献：
  名称：

  碘芳烃的取代基控制、温和氧化氟化：芳基 I(iii)-和 I(v)-氟化物的合成和结构研究†

  摘要：

  我们报告了一种使用三氯异氰尿酸 (TCICA) 和钾合成二氟(芳基)-λ 3 -碘(芳基-IF 2化合物)和四氟(芳基)-λ 5 -碘(芳基-IF 4化合物)的温和方法氟化物（KF）。在这些反应条件下，仅根据碘芳烃起始材料的取代模式即可预测选择性获得 I( III )-或 I( V )-衍生物。此外，这种TCICA/KF方法的发现促使人们对精心设计的探针分子上的IF 2基团和邻位取代基之间的关系进行了详细的动态NMR、动力学、计算和晶体学研究。正是在这些实验中，揭示了邻位取代基在与TCICA和KF反应期间抑制I( III )-化合物进一步氧化氟化为I( V )-化合物的作用。此外，本文还讨论了这一经验趋势的一个值得注意的例外。

  DOI：

  10.1039/c9sc02162k
• 作为产物：
  描述：

  邻氨基三氟甲苯 在 ammonium heptamolybdate sodium perborate 、 亚硝酸特丁酯 、 碘 、 溶剂黄146 、 potassium bromide 作用下， 以 乙腈 为溶剂， 反应 27.0h， 生成 5-溴-2-碘三氟甲苯
  参考文献：
  名称：

  Synthesis and evaluation as MRI probe of the trifluoromethylated p-boronophenylalanine and its alcohol derivative

  摘要：

  Boron-neutron capture therapy (BNCT) and magnetic resonance imaging (MRI) are quite attractive techniques for treatment and diagnosis of cancer, respectively. In order to develop practical tools for BNCT and MRI, novel compounds containing both the trifluoromethyl group and B-10 atom in a single molecule were designed. In the present study, p-boronophenylalanine and p-boronophenylalaninol with the trifluoromethyl group were synthesized, and F-19 NMR measurements of these compounds were carried out. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2006.12.043

文献信息

• NOVEL GPR119 AGONIST COMPOUNDS
  申请人：Mankind Pharma Ltd.

  公开号：US20170291894A1

  公开（公告）日：2017-10-12

  The present invention relates to novel compounds of formula (I), process for preparation of the same and composition comprising these compounds.

  本发明涉及公式（I）的新化合物，其制备方法以及包含这些化合物的组合物。
• [EN] HETEROARYL SODIUM CHANNEL INHIBITORS<br/>[FR] INHIBITEURS DE CANAL SODIUM HÉTÉROARYLE
  申请人：DINEEN THOMAS

  公开号：WO2013025883A1

  公开（公告）日：2013-02-21

  The present invention provides compounds of Formula I or II, or pharmaceutically acceptable salts thereof, that are inhibitors of voltage-gated sodium channels, in particular Nav 1.7. The compounds are useful for the treatment of diseases treatable by inhibition of channels such as pain disorders. Also provided are pharmaceutical compositions containing compounds of the present invention.

  本发明提供了式I或II的化合物，或其药学上可接受的盐，这些化合物是钠通道的抑制剂，特别是Nav 1.7。这些化合物对于治疗通过通道抑制可治疗的疾病，如疼痛障碍，是有用的。还提供了含有本发明化合物的药物组合物。
• BICYCLICALLY SUBSTITUTED URACILS AND THE USE THEREOF
  申请人：BAYER PHARMA AKTIENGESELLSCHAFT

  公开号：US20150148340A1

  公开（公告）日：2015-05-28

  The present application relates to novel bicyclically substituted uracil derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases.

  本申请涉及新颖的双环替代尿嘧啶衍生物，其制备方法，单独或组合使用以治疗和/或预防疾病，以及用于生产治疗和/或预防疾病药物的用途。
• [EN] SUBSTITUTED TRICYCLIC COMPOUNDS WITH ACTIVITY TOWARDS EP1 RECEPTORS<br/>[FR] COMPOSÉS TRICYCLIQUES SUBSTITUÉS POSSÉDANT UNE ACTIVITÉ CONTRE LES RÉCEPTEURS EP1
  申请人：ALMIRALL SA

  公开号：WO2013149997A1

  公开（公告）日：2013-10-10

  The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them.

  本发明属于EP1受体配体领域。更具体地，它涉及具有对EP1受体具有很高亲和力和选择性的一般式(I)化合物。该发明还涉及它们的制备方法，以及它们作为药物用于治疗和/或预防由EP1受体介导的疾病或紊乱，以及包含它们的药物组合物。
• Generation and Suppression of 3-/4-Functionalized Benzynes Using Zinc Ate Base (TMP−Zn−ate):  New Approaches to Multisubstituted Benzenes
  作者：Masanobu Uchiyama、Yuri Kobayashi、Taniyuki Furuyama、Shinji Nakamura、Yumiko Kajihara、Tomoko Miyoshi、Takao Sakamoto、Yoshinori Kondo、Keiji Morokuma

  DOI：10.1021/ja071268u

  日期：2008.1.1

  6-tetramethylpiperidino)zincate (R2Zn(TMP)Li) through deprotonative zincation as a key reaction. In this system, by choosing appropriate ligands for the zincate, either regioselective zincation of functionalized haloaromatics or the generation of substituted benzynes can be controlled in good yields with excellent chemoselectivity, using the same substrate. Zincation with (t)Bu2Zn(TMP)Li followed by electrophilic

  我们详细介绍了我们通过去质子锌化作为关键反应，用二烷基（2,2,6,6-四甲基哌啶基）锌酸锂（R2Zn（TMP）Li）制备功能化苄的新方法的全部细节。在该系统中，通过为锌酸盐选择合适的配体，可以使用相同的底物以良好的产率和优异的化学选择性控制官能化卤代芳烃的区域选择性锌化或取代苄的生成。用 (t)Bu2Zn(TMP)Li 进行锌化，然后进行亲电捕获或用 Me2Zn(TMP)Li 进行锌化，然后进行亲核或二烯捕获，这被证明是化学选择性制备 1,2,3-/1,2 的有力工具,4-三取代苯衍生物。这些方法比以前合成多功能苯的方法具有更大的通用性。这种独特的苄形成反应机理的计算/理论研究表明，锌酸盐的二烷基锌部分与卤素的优先配位是消除活化能降低的原因，即形成苄的原因。还讨论了 Zn 上的配体在加速/减速消除中的作用。